Cluster | 1: Pain tolerant & good cognitions (n = 40) | 2: Restored HPA dynamics (n = 15) | 3: Orthostatic intolerance (n = 20) | 4: Low-grade inflammation (n = 4) | 5: Pain intolerant & poor cognitions (n = 33) | 6: High vagal activity (n = 3) | p-valuec |
---|---|---|---|---|---|---|---|
Sex-no. of males (%) | 7 (17.5) | 4 (26.7) | 7 (35.0) | 1 (25.0) | 10 (30.3) | 1 (33.3) | 0.639 |
Age, years-mean [95% CI] | 15.7 [15.3, 16.3] | 15.7 [14.9, 16.5] | 15.0 [14.2, 15.7] | 16.5 [15.1, 18.0] | 14.8 [14.3, 15.4] | 15.4 [11.2, 19.6] | 0.074 |
BMI, kg/m2-mean [95% CI] | 22.3 [21.0, 23.1] | 23.2[20.4, 26.1] | 20.4 [17.9, 22.6] | 22.8 [11.6, 33.9] | 20.7 [19.4, 22.0] | 18.3 [11.4, 25.1] | 0.128 |
Disease duration, months-mean [95% CI] | 19.4 [15.9, 22.9] | 25.1 [10.8, 39.5] | 22.0 [16.0, 27.9] | 28.0 [n.a.] | 19.3 [14.8, 23.9] | 30.3 [n.a.] | 0.538 |
Fukuda-no. fulfilling criteria (%)a | 27 (71.1) | 9 (60.0) | 16 (80.0) | 4 (100.0) | 25 (78.1) | 3 (100.0) | 0.564 |
Canada-no. fulfilling criteria (%)b | 13 (35.1) | 3 (20.0) | 6 (30.0) | 1 (25.0) | 22 (68.8) | 1 (33.3) | 0.006 |
COMT [SNP rs4680]-no. (%) | |||||||
AA | 10 (25.0) | 4 (26.7) | 8 (40.0) | 1 (25.0) | 13 (39.4) | 0 (0) | 0.616 |
AG/GG | 30 (75.0) | 11 (73.3) | 12 (60.0) | 3 (75.0) | 20 (60.6) | 3 (100.0) | |
SLC6A4 [5-HTTLPR allele & SNP rs25531]-no. (%) | |||||||
SS/SLG | 11 (27.5) | 3 (20.0) | 2 (10.0) | 3 (75.0) | 9 (27.3) | 1 (66.7) | 0.139 |
SA/LALG/LALA | 29 (27.5) | 20 (80.0) | 18 (90.0) | 1 (25.0) | 24 (72.7) | 2 (33.3) |